L. Reuteri is a bacterium that may influence digestion, immunity, and mood through mechanisms still being mapped

L. reuteri is a strain of lactic acid bacteria found naturally in the human gut and in some fermented foods. Unlike many probiotics studied in controlled trials, L. reuteri has shown effects in both animal and human research on digestion, immune response, and even mood-related pathways. The evidence is real but uneven: some effects are well-documented in small human studies, while others rest mainly on animal work or remain preliminary.

The bacterium appears to work through several routes. It produces compounds that lower gut pH, making the environment less hospitable to harmful bacteria. It also produces short-chain fatty acids—particularly butyrate—which feed the cells lining your intestine and may reduce inflammation. Some strains produce histamine or influence serotonin pathways, which could explain reported mood effects, though this research is newer and less settled.

L. reuteri does not colonize the human gut permanently the way some bacteria do. When you stop consuming it, levels drop within weeks. This means any benefit requires ongoing intake, and it also means the risk of long-term accumulation is low.

Key Takeaways

  • L. reuteri may reduce digestive symptoms like bloating and constipation in some people, with the strongest evidence in infants with colic and in adults with irritable bowel syndrome.
  • Animal studies show it can reduce inflammation and support immune cell development, but human trials on immunity are small and do not yet show clinical disease prevention.
  • Emerging research suggests L. reuteri may influence mood and anxiety through gut-brain signaling, but this evidence comes mostly from animal studies and one small human trial.
  • L. reuteri does not establish permanent colonies in the gut, so benefits appear only while you are consuming it and fade after you stop.
  • Common food sources include some fermented dairy products and certain probiotic supplements; the dose and strain matter, as different strains have different effects.

How L. Reuteri Affects Digestion and Gut Health

The most consistent evidence for L. reuteri involves infant colic. Multiple randomized controlled trials—the gold standard in human research—have found that L. reuteri supplementation reduces crying time and fussiness in breastfed infants, with effects appearing within one to two weeks. The mechanism appears to involve reduced gas production and faster gastric emptying, though the exact pathway is not fully understood.

In adults, the evidence is weaker but suggestive. Observational studies and small trials report that L. reuteri may reduce bloating, constipation, and abdominal discomfort in people with irritable bowel syndrome. A 2021 randomized trial published in Nutrients found that a specific strain (ATCC PTA 6475) reduced IBS symptoms over eight weeks, but the effect size was modest and the study included only 60 participants. Larger, longer trials are needed to confirm whether this benefit holds across different populations and strains.

The mechanism likely involves short-chain fatty acid production and a shift in the microbial community that reduces gas-producing bacteria. L. reuteri also produces reuterin, a compound with antimicrobial properties that may suppress overgrowth of problematic species. However, these effects are strain-specific—not all L. reuteri strains produce reuterin, and not all produce the same amounts.

Immune Function and Inflammation: What Animal and Human Studies Show

Animal research on L. reuteri and immunity is extensive and consistent. Studies in mice show that certain strains increase the number and function of regulatory T cells—immune cells that dampen excessive inflammation—and enhance the production of antibodies. These findings have led to interest in L. reuteri for allergies, asthma, and autoimmune conditions.

Human trials, however, are limited and results are mixed. A small randomized trial in children found that L. reuteri reduced the incidence of respiratory infections over three months, but the study included only 122 children and the effect was modest. Another trial in adults with allergic rhinitis found no significant benefit. A 2020 review in Nutrients concluded that while animal evidence is promising, human data do not yet support recommending L. reuteri specifically for immune support or disease prevention outside of specific contexts like infant colic.

One area with more consistent human data is oral health. Several small trials found that L. reuteri lozenges reduced plaque and gum inflammation in people with gingivitis, likely through local antimicrobial effects in the mouth. This is one of the few areas where L. reuteri has moved from animal evidence to repeated human confirmation, though studies remain small.

Mood, Anxiety, and the Gut-Brain Axis

The idea that gut bacteria influence mood through the gut-brain axis—a two-way communication system involving the vagus nerve, immune signaling, and microbial metabolites—has moved from fringe to mainstream neuroscience. L. reuteri is one of the few bacterial strains with direct experimental evidence for this pathway, though almost all of it comes from animal work.

In mice, L. reuteri administration reduces anxiety-like behavior in standard tests and increases social interaction. The mechanism appears to involve increased production of oxytocin, a neurochemical linked to social bonding and stress relief. Some strains also influence GABA and serotonin pathways. These effects are robust in rodent models, but rodent behavior does not always translate to human psychology.

Human evidence is scarce. One small randomized trial in 34 adults found that L. reuteri supplementation reduced self-reported anxiety over eight weeks compared to placebo. Another trial in 40 adults with depression found modest improvements in mood scores. Both studies are preliminary—small sample sizes, short duration, and potential for bias mean they cannot yet support a clinical recommendation. A larger, well-designed trial would be needed to know whether L. reuteri genuinely affects human mood or whether the effect is placebo.

Food Sources and Supplement Forms

L. reuteri occurs naturally in some fermented foods, though levels vary widely and are often too low to match research doses. Certain yogurts, kefir, and fermented vegetables may contain L. reuteri, but manufacturers do not always list specific strains, and pasteurization kills the bacteria. If you want a known dose of a specific strain, a supplement is more reliable than food.

Supplements come as capsules, powders, or lozenges. Common strains in commercial products include ATCC PTA 6475, DSM 17938, and LTr04. Research on infant colic has used DSM 17938 and ATCC PTA 6475; research on IBS has used ATCC PTA 6475; research on mood has used various strains. Doses in studies typically range from 10 billion to 100 billion colony-forming units (CFU) per day, though there is no established optimal dose.

Quality varies among brands. Third-party testing through organizations like NSF International or USP can confirm that a product contains the stated strain and CFU count, but most supplements are not tested this way. If you are considering L. reuteri, checking the label for a specific strain name and CFU count is more informative than a generic "probiotic blend."

Who Might Benefit and Who Should Be Cautious

The clearest evidence supports L. reuteri for breastfed infants with colic. If you have an infant with persistent crying and your pediatrician has ruled out other causes, a trial of L. reuteri DSM 17938 is reasonable and supported by multiple trials. Improvement typically appears within one to two weeks.

For adults with IBS, the evidence is suggestive but not conclusive. If you have tried dietary changes and other interventions without relief, a trial of L. reuteri may be worth exploring, particularly if you have constipation or bloating as primary symptoms. Expect to take it for at least four to eight weeks to assess benefit.

For mood and anxiety, current evidence does not support L. reuteri as a primary treatment. If you have depression or anxiety, work with a mental health provider on evidence-based approaches first. L. reuteri might be considered an adjunct, but it is not a substitute for therapy or medication.

L. reuteri is generally well-tolerated. Mild digestive upset—bloating, gas, or loose stools—can occur in the first few days as the microbial community shifts, but this usually resolves. People with severe immunosuppression or central venous catheters should consult a doctor before taking any probiotic, as there is a theoretical risk of bacteremia, though this is rare.

What Remains Unknown

The biggest gap is the lack of large, long-term human trials. Most studies last four to twelve weeks; we do not know whether L. reuteri benefits persist beyond that or what happens with years of use. We also do not know which strains work best for which conditions—the research uses different strains, making it hard to compare results or recommend one over another.

The dose question is also unsettled. Studies use doses ranging from 10 billion to 100 billion CFU, but there is no dose-response research showing whether more is better or whether a lower dose works just as well. Individual variation in gut microbiota composition, diet, and genetics likely means that L. reuteri works better for some people than others, but we cannot yet predict who will respond.

Finally, most research has focused on specific strains in controlled settings. Real-world use—where you are also eating different foods, taking other supplements, and managing stress—may produce different results than what laboratory trials show.

Frequently Asked Questions

Is L. reuteri the same as other probiotics?

No. L. reuteri is one specific bacterial species; probiotics is a broad category that includes many species and strains. Different strains have different effects. L. reuteri has more research on specific mechanisms than many probiotics, but that does not mean it works better for all conditions—it just means we know more about how it works.

Can I get enough L. reuteri from food alone?

Possibly, but it is hard to know. Some fermented foods contain L. reuteri, but levels are unpredictable and often lower than research doses. If you want a consistent dose of a specific strain, a supplement is more reliable than relying on food sources.

How long does it take to feel a benefit?

In infant colic research, effects appear within one to two weeks. In adult IBS studies, benefits typically emerge over four to eight weeks. For mood effects, the one human trial used eight weeks. If you do not notice a change after six to eight weeks, it may not work for you.

What happens if I stop taking L. reuteri?

L. reuteri does not permanently colonize the gut, so levels drop within weeks of stopping. Any benefit will likely fade over the same timeframe. This means you would need to continue taking it to maintain effects, but it also means there is no risk of long-term accumulation.

Can L. reuteri interact with medications?

Direct interactions are rare, but L. reuteri may theoretically affect how your gut absorbs some medications. If you take medications for a chronic condition, mention L. reuteri to your doctor or pharmacist, particularly if you are immunosuppressed or have a serious illness.